SHENZHEN, China, Feb. 27 /PRNewswire-Asia/ -- Winner Medical Group Inc. (OTC Bulletin Board: WMDG; "Winner Medical", the "Company"), a leading manufacturer in the Chinese medical dressing industry (medical and wound care products), today announced that the European Patent Office has decided to grant the patent for producing PurCotton(TM) products to Winner Medical. The following are specifically covered by the patent: method for producing spunlace non-woven cloth, method for producing spunlace non-woven cloth with X-ray detectable element and spunlace non-woven cloth with X-ray detectable element produced thereby.
Mr. Jianquan Li, CEO of Winner Medical, remarked, "This means the achievement of another important milestone. The European patent enables us to plan on a long-term basis and to advance the market entry for our PurCotton(TM) products steadily. Now we have valid national rights in approximately 34 member states of the European Patent Office."
As of February 2009, Winner Medical has obtained patents for PurCotton(TM) products in several countries, including China, the U.S.A., Russia, Singapore, South Africa, and 34 member states of the European Patent Office. The patent application is also pending in other regions such as Japan, South America, India and the Middle East.
PurCotton(TM) products combine the superior characteristics of both
natural cotton and materials made using nonwoven technology. It has many
advantages over both woven cotton and synthetic nonwoven fabric, as it is of
high quality, natural, safe, strong, durable, healthy and
environmentally-friendly. Winner Medical's patented manufacturing process
enables the Company to produce PurCotton(TM) at a lower cost than the woven
cotton products, and it can therefore offer customers a lower price without
sacrificing its margin. The Company expects the new PurCotton(TM) products to
be a medium to long term growth contributo
|SOURCE Winner Medical Group Inc.|
Copyright©2009 PR Newswire.
All rights reserved